FirmaIQ
Org.nr 815 643 062 2024 → 2025 Year-over-year analysis

ADESSO BIOPRODUCTS AS: årsregnskap 2025 vs 2024

Shrank 6% on revenue, stronger earnings

approved 2026-02-27; registry 2026-03-09; journal 2026 328272

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2025 with 2024 for ADESSO BIOPRODUCTS AS. Revenue 52.54m NOK → 49.16m NOK (-6.4%). Net result +2.12m NOK → +2.83m NOK. Equity 43.73m NOK → 46.55m NOK.

On the constructive side: operating result improved; net result improved; equity strengthened. Pressures included: revenue fell.

Also worth watching: cogs fell; headcount (årsverk) changed. All figures are taken from the published annual accounts for ADESSO BIOPRODUCTS AS.

At a glance

Scorecard

Revenue
52.54m NOK 49.16m NOK
-6.4%
Operating result
+2.66m NOK +3.57m NOK
+34.0%
Net result
+2.12m NOK +2.83m NOK
+33.2%
Equity
43.73m NOK 46.55m NOK
+6.5%
Cash
21.89m NOK 29.11m NOK
+33.0%
Total assets
59.85m NOK 54.80m NOK
-8.4%

What improved

  • ↑

    Operating result improved

    Operating result +2.66m NOK → +3.57m NOK (op. margin 5.1% → 7.3%). Calculated

  • ↑

    Net result improved

    Net result +2.12m NOK → +2.83m NOK (net margin 4.0% → 5.8%). Calculated

  • ↑

    Equity strengthened

    Book equity 43.73m NOK → 46.55m NOK (equity ratio 73.1% → 84.9%). Calculated

  • ↑

    Cash rose

    Bank deposits 21.89m NOK → 29.11m NOK (+33.0% YoY). Calculated

  • ↑

    Payroll decreased

    Salary cost 17.91m NOK → 16.84m NOK (34% → 34% of revenue). Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 52.54m NOK to 49.16m NOK (-6.4% YoY). Calculated

Things to notice

  • ·

    COGS fell

    COGS / varekostnad 12.64m NOK → 9.81m NOK (-22.4% YoY). Calculated

  • ·

    Headcount (årsverk) changed

    Reported FTEs 20 → 16. Reported fact